Genomic Health (GHDX)
Genomic Health Capital Expenditures: 2.342M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
GHDX Capital Expenditures Rankings
| Overall | 49th percentile | 2266 of 4449 |
| Sector | 30th percentile | 352 of 507 in Healthcare |
| Industry | 43rd percentile | 14 of 25 in Medical Laboratories & Research |
GHDX Capital Expenditures Range, Past 5 Years
| Minimum | 0.315M | Mar 2009 |
| Maximum | 2.859M | Sep 2008 |
| Average | 1.495M |
About Capex
Capital expenditures are a line item from a company's statement of cash flows (click "Learn More" below for details).
Capex (short for capital expenditures) are incurred when a business spends money to purchase fixed assets or to add value to an existing fixed asset. In accounting, a capital expenditures are added to an asset account, thus increasing the value of the asset.
Examples of capital expenditures include the purchase of a new manufacturing plant, investment in server farms for tech companies, or other purchases of assets expected to help the company earn profits in the future.
Unlike other investments like research and development and marketing spending, capital expenditures are not immediately expensed. Rather, property, plant and equipment acquired using capital expenditures are usually expensed over time through the use of depreciation.
Learn More
You may also be interested in these GHDX related companies
GHDX News
NEW POST: "A Bit Too Rare" http://stks.co/3ySS $GENE $GHDX $MYGN $QQQ $ROSG $SPY
about 5 days ago by chessNwine
about 5 days ago by chessNwine
$GHDX Insider Buy: $5.4M of stock bought by Felix Baker between May 21, 2012 - May 22, 2012 http://stks.co/3xjR
about 6 days ago by MarketBrief
about 6 days ago by MarketBrief
$GHDX Insider Buy: $12.7M of stock bought by Felix Baker between May 14, 2012 - May 16, 2012 http://stks.co/3rdD
about 13 days ago by MarketBrief
about 13 days ago by MarketBrief
10 breakouts: $BONA, $GHDX. Two sub-$1 and no penny stocks. Slow day but no focus on weak stocks, just a lack of interest
about 15 days ago by fallondpicks
about 15 days ago by fallondpicks
Genomic Health, Marriott Vacations Worldwide Among Stocks Setting 52-Week Highs Monday
May 14, 4:32PM Fox Business
May 14, 4:32PM Fox Business
$GHDX Another Baker Brothers favorite, crushing it over the last 6 trading days. This kind of move & volume in this crappy market? Whats up?
about 15 days ago by PTSD_Trader
about 15 days ago by PTSD_Trader
Ruparelia's picks in diagnostic testing, robots and 3D printing: $GHDX $IRBT $SSYS $DDD http://stks.co/3nhk
about 16 days ago by covestor
about 16 days ago by covestor
$GHDX I like the volume/accumulation here. Keeping on watch list. New name for me. http://chart.ly/bl5p3dd
about 17 days ago by BrettPerlman
about 17 days ago by BrettPerlman
$GHDX Insider Buy: $3.4M of stock bought by Felix Baker between May 9, 2012 - May 11, 2012 http://stks.co/3nPM
about 18 days ago by MarketBrief
about 18 days ago by MarketBrief
$GHDX Insider Buy: $5.6M of stock bought by Felix Baker between May 4, 2012 - May 8, 2012 http://stks.co/3jWm
about 21 days ago by MarketBrief
about 21 days ago by MarketBrief
Canaccord Genuity Maintains a 'Hold' on Genomic Health (GHDX); Raising PT and Estimates
May 03, 9:44AM Street Insider
May 03, 9:44AM Street Insider
Genomic Health Announces First Quarter 2012 Financial Results and Business Progress
May 02, 4:01PM PR Newswire
May 02, 4:01PM PR Newswire
Genomic Health (GHDX) to Report New Data from Recent Oncotype DX Clinicals
Mar 21, 7:03AM Street Insider
Mar 21, 7:03AM Street Insider
$GHDX http://stks.co/2p6Y Continues to act well on nice price & volume profile. Back near HOD.
about 77 days ago by Fibline
about 77 days ago by Fibline
Baker Bros stake in $GHDX is now over 35% of the whole company. There's really only one way to sell out of a position like that one day.
about 79 days ago by bradloncar
about 79 days ago by bradloncar
RT @ElliotTurn: Best idea from Barron's= $GHDX, w/ Baker Bros. accumulating a massive stake in the provider of personalized genomics-based
about 80 days ago by WallStJesus
about 80 days ago by WallStJesus
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| GHDX | 34.67 | +0.11 | +0.32% | 1.036B |
| GGT | 6.72 | +0.08 | +1.20% | |
| GGR | 0.1999 | -0.00 | -0.05% | 19.83M |
| GGP | 17.07 | +0.26 | +1.55% | |
| FRT | 99.42 | +0.83 | +0.84% | 6.277B |
| FRS | 27.18 | -0.04 | -0.15% | 134.47M |
| FRP | 5.39 | -0.13 | -2.36% | |
| FRO | 5.31 | -0.07 | -1.30% | 418.89M |
| FORTY | 16.00 | -0.22 | -1.36% | 226.24M |
| FORR | 33.27 | -0.04 | -0.12% | 755.14M |
